TipRanks on MSN
Sanofi’s SAR445399 study: A potential breakthrough in hidradenitis suppurativa treatment
Sanofi ($SNYNF) announced an update on their ongoing clinical study. Study Overview: Sanofi is conducting a Phase 2 clinical trial titled A ...
TipRanks on MSN
Sanofi’s dupilumab study completion: Implications for asthma treatment and market impact
Sanofi ($SNYNF) announced an update on their ongoing clinical study. Sanofi recently completed a study titled ‘National, Multicenter, ...
With Qfitlia and Cablivi, Sanofi reaches its fourth and fifth approvals in China this year, following Tzield for stage 2 type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback